The serum levels of resistin in rheumatoid arthritis patients

Clinical and Experimental Rheumatology

Volumn 24, Issue 6, 2006, Pages 698-701

  Migita, Kiyoshi ^a   Maeda, Yumi ^a   Miyashita, Taichiro ^a   Kimura, Hironori ^a   Nakamura, Minoru ^a   Ishibashi, Hiromi ^a   Eguchi, Katsumi ^b  

^a NATIONAL HOSPITAL ORGANIZATION NAGASAKI MEDICAL CENTER   (Japan)

^b NAGASAKI UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Cytokine; Resistin; Rheumatoid arthritis; Tumor necrosis factor

Indexed keywords

C REACTIVE PROTEIN; DISEASE MODIFYING ANTIRHEUMATIC DRUG; METHOTREXATE; RESISTIN; STEROID; TUMOR NECROSIS FACTOR ALPHA;

ADULT; AGED; ARTICLE; BLOOD SAMPLING; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; DISEASE ACTIVITY; ENZYME LINKED IMMUNOSORBENT ASSAY; ERYTHROCYTE SEDIMENTATION RATE; FEMALE; HUMAN; INFLAMMATORY DISEASE; MALE; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN DETERMINATION; RHEUMATOID ARTHRITIS;

ADULT; AGED; AGED, 80 AND OVER; ARTHRITIS, RHEUMATOID; C-REACTIVE PROTEIN; CASE-CONTROL STUDIES; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMANS; MALE; MIDDLE AGED; RESISTIN; TUMOR NECROSIS FACTOR-ALPHA;

EID: 33846438219     PISSN: 0392856X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (16)

1. HAVEL PJ: Update on adipocyte hormones: regulation of energy balance and carbohydrate/lipid metabolism. Diabetes 2004; 53 (Suppl. 1): S143-51.
2. FASSHAUER M: PASCHKE R: Regulation of adipocytokines and insulin resistance. Diabetologia 2003; 46: 1594-603.
3. LYON CJ, LAW RE, HSUEH WA: Minireview: adiposity, inflammation, and atherogenesis. Endocrinology 2003; 144: 2195-200.
4. STEPPAN CM, BROWN EJ, WRIGHT CM et al.: family of tissue-specific resistin-like molecules. Proc Natl Acad Sci U S A 2001; 98: 502-6.
5. STEPPAN CM, BAILEY ST, BHAT S et al.: The hormone resistin links obesity to diabetes. Nature 2001; 409: 307-12.
6. LEE JH, CHAN JL, YIANNAKOURIS N et al.: Circulating resistin levels are not associated with obesity or insulin resistance in humans and are not regulated by fasting or leptin administration: cross-sectional and interventional studies in normal, insulin-resistant, and diabetic subjects. J Clin Endocrinol Metab 2003; 88: 4848-56.
7. PATEL L, BUCKELS AC, KINGHORN IJ et al.: Resistin is expressed in human macrophages and directly regulated by PPAR gamma activators. Biochem Biophys Res Commun 2003; 300: 472-6.
8. FELDMANN M, BRENNAN FM, MAINI RN: Role of cytokines in rheumatoid arthritis. Annu Rev Immunol 1996; 14: 397-440.
9. STEPPAN CM, LAZAR MA: Resistin and obesity-associated insulin resistance. Trends Endocrinol Metab 2002; 13: 18-23.
10. BOKAREWA M, NAGAEV I, DAHLBERG L, SMITH U, TARKOWSKI A: Resistin, an adipokine with potent proinflammatory properties. J Immunol 2005; 174: 5789-95.
11. HEILBRONN LK, ROOD J, JANDEROVA L et al.: Relationship between serum resistin concentrations and insulin resistance in non-obese, obese, and obese diabetic subjects. J Clin Endocrinol Metab 2004; 89: 1844-8.
12. LEHRKE M, REILLY MP, MILLINGTON SC, IQBAL N, RADER DJ, LAZAR MA: An inflammatory cascade leading to hyperresistinemia in humans. PLoS Med 2004; 1: 45-52.
13. OTERO M, LAGO R, GOMEZ R et al.: Changes in fat-derived hormones plasma concentrations: adiponectin, leptin, resistin, and visfatin in rheumatoid arthritis subjects. Ann Rheum Dis 2006; Jan 13; [Epub ahead of print]
14. MARADIT-KREMERS H, NICOLA PJ, CROWSON CS, BALLMAN KV, GABRIEL SE: Cardiovascular death in rheumatoid arthritis: a population-based study. Arthritis Rheum 2005; 52: 722-32.
15. SNOW MH, MIKULS TR: Rheumatoid arthritis and cardiovascular disease: the role of systemic inflammation and evolving strategies of prevention. Curr Opin Rheumatol 2005; 7: 234-41.
16. REILLY MP, LEHRKE M, WOLFE ML, ROHATGI A, LAZAR MA, RADER DJ: Resistin is an inflammatory marker of atherosclerosis in humans. Circulation 2005; 111: 932-9.